Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Anticancer Research|December 11, 2013
EGFRvIII--a stable target for anti-EGFRvIII therapyMateusz Banaszczyk, Ewelina Stoczynska-Fidelus, Marta Winiecka-Klimek, et al.
Stem Cell Research & Therapy|June 20, 2015
Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming systemAnna M Drozd, Maciej P Walczak, Sylwester Piaskowski, et al.
BMC Cancer|July 2, 2025
The complex journey of targeting RAS in oncologyKatarzyna Wasiak, Damian Ciunowicz, Amelia Kierasińska-Kałka, et al.
Leukemia & Lymphoma|June 30, 2004
Multiple myeloma in a patient with systemic lupus erythematosus, myasthenia gravis and non-familial diffuse palmoplantar keratodermaHalina Urbańska-Ryś, Ewa Robak, RadzisŁaw Kordek, et al.
Folia Neuropathologica|April 13, 2010
Imperfect oligodendrocytic and neuronal differentiation of glioblastoma cellsMagdalena Wolańczyk, Krystyna Hułas-Bigoszewska, Monika Witusik-Perkowska, et al.
Materials Science & Engineering. C, Materials for Biological Applications|December 27, 2015
Synthesis and physicochemical characterization of chitin dihexanoate--A new biocompatible chitin derivative--In comparison to chitin dibutyrateKarolina Skołucka-Szary, Aleksandra Ramięga, Wanda Piaskowska, et al.
Materials Science & Engineering. C, Materials for Biological Applications|June 29, 2015
Chitin dipentanoate as the new technologically usable biomaterialKarolina Skołucka-Szary, Aleksandra Ramięga, Wanda Piaskowska, et al.
Neuroscience Letters|March 8, 2006
Regulation of PrPC expression: nerve growth factor (NGF) activates the prion gene promoter through the MEK1 pathway in PC12 cellsIzabela Zawlik, Monika Witusik, Krystyna Hulas-Bigoszewska, et al.
Pageof 7